Published in Blood Weekly, December 29th, 2005
Study 1: Patients fare well without steroids after hepatitis C-related liver transplants.
"To examine the benefits of steroid avoidance in adult living donor liver transplantation, we compared the clinical courses of nine recipients receiving basiliximab or daclizumab and 13 historical patients who received steroids," researchers in Japan report.
"The 1-year patient and graft survival and the incidence of acute cellular rejection were similar in both groups," according to S. Marubashi and colleagues, Osaka University.
Researchers said...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2005-12-29)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.